Antibody response to Plasmodium vivax antigens in Fy-negative individuals from the Colombian Pacific coast

The Duffy antigen (Fy) is necessary for Plasmodium vivax invasion of human erythrocytes. Some populations have a highly prevalent Fy-negative phenotype; such persons are naturally protected from P. vivax blood infection but are expected to completely support the P. vivax pre-erythrocytic cycle, repr...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of tropical medicine and hygiene Vol. 73; no. 5 Suppl; p. 44
Main Authors: Herrera, Sócrates, Gómez, Andrés, Vera, Omaira, Vergara, Juana, Valderrama-Aguirre, Augusto, Maestre, Amanda, Méndez, Fabián, Wang, Ruobing, Chitnis, Chetan E, Yazdani, Syed S, Arévalo-Herrera, Myriam
Format: Journal Article
Language:English
Published: United States 01-11-2005
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Duffy antigen (Fy) is necessary for Plasmodium vivax invasion of human erythrocytes. Some populations have a highly prevalent Fy-negative phenotype; such persons are naturally protected from P. vivax blood infection but are expected to completely support the P. vivax pre-erythrocytic cycle, representing a valuable model for studying the immune response during these parasitic stages. We typed 214 individuals, mostly Afro-Colombians, from a P. vivax-endemic area for Fy expression and determined the antibody response to P. vivax pre-erythrocytic (sporozoites and CS) and blood-stage antigens (blood forms, P. vivax merozoite surface protein 1, and P. vivax Duffy binding protein [PvDBP]). Antibody titers to P. vivax circumsporozoite protein, P11, and N-terminal peptides and the number of responders were similar in Fy-negative and Fy-positive individuals. The number of responders to sporozoites, blood forms, and PvDBP were different between these groups. Thus, Fy-negative individuals from malaria-endemic areas can be used to study the immune response to the P. vivax liver phase without interference of the erythrocytic cycle.
ISSN:0002-9637
DOI:10.4269/ajtmh.2005.73.44